Carolyn R. Bertozzi, Ph.D.

Carolyn R. Bertozzi, Ph.D., is the Baker Family Director of Sarafan ChEM-H, the Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences, and Professor, by courtesy, of Chemical and Systems Biology and of Radiology at Stanford University.  Bertozzi is also an Investigator of the Howard Hughes Medical Institute. She was re-elected to the Eli Lilly and Company board of directors in 2025 and previously served on the board from 2017 to 2021.

32px

She completed her undergraduate degree in chemistry from Harvard University in 1988 and her doctorate in chemistry from University of California, Berkeley, in 1993. After completing postdoctoral work at University of California, San Francisco, in the field of cellular immunology, Bertozzi joined the UC Berkeley faculty in 1996. In June 2015, she joined the faculty at Stanford University and became the co-director and Institute Scholar at Sarafan ChEM-H.

16px

Bertozzi's research interests span the disciplines of chemistry and biology with an emphasis on studies of cell surface glycosylation pertinent to disease states. Her lab focuses on profiling changes in cell surface glycosylation associated with cancer, inflammation, and bacterial infection and exploiting this information for development of diagnostic and therapeutic approaches, most recently in the area of immuno-oncology.

She has been recognized with many honors and awards for her research accomplishments. Bertozzi is an elected member of the National Academy of Medicine, National Academy of Sciences, the American Academy of Arts and Sciences, and the German Academy of Sciences Leopoldina. Some awards of note include the Nobel Prize in Chemistry, Lemelson-MIT award for inventors, Whistler Award, Ernst Schering Prize, MacArthur Foundation Fellowship, the ACS Award in Pure Chemistry, Tetrahedron Young Investigator Award, and Irving Sigal Young Investigator Award of the Protein Society.

16px

Explore More

32px

Learn more about our team

48px

48px